Literature DB >> 9624343

Is it possible to predict limb viability in complex Gustilo IIIB and IIIC tibial fractures? A comparison of two predictive indices.

S T O'Sullivan1, M O'Sullivan, N Pasha, M O'Shaughnessy, T P O'Connor.   

Abstract

The patient with severe lower limb trauma presents a management dilemma; whether to amputate primarily or to attempt limb salvage. In recent years, many predictive indices have been published which purport to identify limbs which are non-viable. We retrospectively applied two recently described indices, the Mangled Extremity Severity Score (MESS) and the Limb Salvage Index (LSI), to 54 limbs in 50 patients with either Gustilo IIIB or IIIC complex tibial fractures. There were 22 amputations (40.7 per cent) in the series. The mean MESS score in the limb salvage group was 3.8 (range 2-10), and the mean MESS score in the amputation group was 7.7 (range 4-13) (P < 0.0001). The mean LSI score in the limb salvage group was 3.6 (range 3-8), and the mean LSI score in the amputation group was 6.9 (P < 0.01). However, in the group with MESS scores > 7 (which recommends amputation), there were three limbs which were salvaged with acceptable functional outcome. Similarly, in those with LSI scores > 6 (which recommends amputation), there were seven limbs successfully salvaged. A MESS > 7 offered a greater relative risk of amputation (9.2) than a LSI score > 6 (5.3). We found both indices of use in predicting limb salvage and functional outcome. However, neither is sufficiently accurate to be considered absolutely reliable in clinical practice.

Entities:  

Mesh:

Year:  1997        PMID: 9624343     DOI: 10.1016/s0020-1383(97)00134-4

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  11 in total

Review 1.  A systematic review of outcomes and complications of reconstruction and amputation for type IIIB and IIIC fractures of the tibia.

Authors:  Daniel Saddawi-Konefka; Hyungjin Myra Kim; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2008-12       Impact factor: 4.730

2.  Ability of lower-extremity injury severity scores to predict functional outcome after limb salvage.

Authors:  Thuan V Ly; Thomas G Travison; Renan C Castillo; Michael J Bosse; Ellen J MacKenzie
Journal:  J Bone Joint Surg Am       Date:  2008-08       Impact factor: 5.284

3.  Salvage versus amputation: Utility of mangled extremity severity score in severely injured lower limbs.

Authors:  M Kiran Kumar; Cm Badole; Kr Patond
Journal:  Indian J Orthop       Date:  2007-07       Impact factor: 1.251

4.  Mangled lower extremity: can we trust the amputation scores?

Authors:  Lucian Fodor; Raluca Sobec; Laura Sita-Alb; Marius Fodor; Constantin Ciuce
Journal:  Int J Burns Trauma       Date:  2012-02-05

5.  Management of the mangled extremity.

Authors:  Mark L Prasarn; David L Helfet; Peter Kloen
Journal:  Strategies Trauma Limb Reconstr       Date:  2012-06-13

6.  Scoring systems in trauma.

Authors:  R Kingston; S J O'Flanagan
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 2.089

7.  Treatment principles in the management of open fractures.

Authors:  William W Cross; Marc F Swiontkowski
Journal:  Indian J Orthop       Date:  2008-10       Impact factor: 1.251

8.  Total posterior leg open wound management with free anterolateral thigh flap: case and literature review.

Authors:  Soleiman Osman; Stephanie Chou; James Rosing; David E Sahar
Journal:  Eplasty       Date:  2013-09-27

Review 9.  Primary amputation vs limb salvage in mangled extremity: a systematic review of the current scoring system.

Authors:  Giuseppe Rosario Schirò; Sergio Sessa; Andrea Piccioli; Giulio Maccauro
Journal:  BMC Musculoskelet Disord       Date:  2015-12-02       Impact factor: 2.362

10.  Predictors of secondary amputation in patients with grade IIIC lower limb injuries: A retrospective analysis of 35 patients.

Authors:  Wenhao Song; DongSheng Zhou; Jinlei Dong
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.